黑料网 Urology proudly announces that Dr. Mary Beth Westerman, a newly appointed faculty member, has been selected to serve on the , a key subcommittee of the Science & Quality Committee.
The appointment to the AUA Practice Guidelines Committee represents an exciting step forward for both 听Dr. Westerman and 黑料网 Urology. Her expertise, research acumen, and commitment to evidence-based medicine will contribute to advancing national practice standards and enhancing patient outcomes.
A Prolific Researcher and Leader in Urologic Oncology
Dr. Westerman brings a wealth of experience to 黑料网 Urology, with a distinguished early career dedicated to advancing the treatment of complex urologic cancers, including bladder, kidney, prostate, and testicular cancers. Her research focuses on bladder cancer, clinical trials, minimizing length of stay and enhancing early recovery, as well as quality improvement and process optimization in oncologic care and treatment decision-making.
She has been a co-investigator on multiple prestigious research grants, including an R01 for bladder cancer treatment and has played a pivotal role in national clinical trials. She serves as the Patient-Reported Outcomes Co-Chair for the ARCHER cooperative trial, which is investigating adaptive chemotherapy and radiation for muscle-invasive bladder cancer. Additionally, she previously served as Site PI for the PCORI-funded CISTO trial (Co-PI: Dr. Angela Smith) and the SWOG-sponsored BRIDGE trial, both aimed at advancing treatments for non-muscle invasive bladder cancer.
Beyond her research contributions, Dr. Westerman is widely recognized for her leadership and service within the urologic oncology community. She served on the Steering Committee for the Young Urologic Oncologist section of the Society of Urologic Oncology (SUO) and the Board of Directors for the Society of Urologic Oncologists 鈥� Clinical Trials Committee (SUO-CTC).
Strengthening 黑料网 Urology鈥檚 Leadership in the AUA
With Dr. Westerman鈥檚 new appointment, 黑料网 Urology now has multiple faculty members holding key leadership roles within the AUA鈥檚 Science & Quality governance:
- Dr. Matthew Nielsen serves as Chair of the AUA鈥檚 Science and Quality Council, leading national initiatives in quality improvement, patient safety, and guideline development.
- Dr. Dave Friedlander is a member of the AUA鈥檚 Quality Improvement and Patient Safety (QIPS) Committee, which focuses on enhancing patient safety and surgical outcomes.
- Dr. Hung-Jui (Ray) Tan serves as Chair of the AUA Data Committee, leading efforts in data-driven approaches to improve urological care.
The collective involvement of 黑料网 Urology faculty in AUA leadership reflects the department鈥檚 growing influence in shaping national healthcare policy, clinical guidelines, and quality initiatives.